Frimodt-Möller N, Maigaard S, Madsen P O
Antimicrob Agents Chemother. 1979 Sep;16(3):406-10. doi: 10.1128/AAC.16.3.406.
The efficacy and tolerance of netilmicin was studied in 28 elderly male patients with varying degrees of renal function impairment who suffered from complicated urinary tract infections. Doses of netilmicin, equivalent to 2 mg/kg divided by milligrams of creatinine per 100 ml, were administered every 12 h. A 62% cure rate, defined as negative urine culture at 1-week follow-up, was obtained. Treatment failure correlated with impaired renal function. Nephrotoxic reaction, defined as any significant increase in serum creatinine during treatment, was found in 6 of 28 patients (21%). The increase in serum creatinine was transient in all except one of these patients. Apart from the finding of a significant correlation between nephrotoxic reaction to netilmicin and postoperative urinary tract infection, no clinical or therapeutic features correlated with nephrotoxicity; trough concentrations correlated with serum creatinine.
对28例患有复杂性尿路感染且肾功能有不同程度损害的老年男性患者,研究了奈替米星的疗效和耐受性。每12小时给予奈替米星剂量,相当于每100ml肌酐毫克数除以2mg/kg。随访1周时尿培养阴性定义为治愈率为62%。治疗失败与肾功能损害相关。28例患者中有6例(21%)出现肾毒性反应,定义为治疗期间血清肌酐显著升高。除1例患者外,所有患者血清肌酐升高均为一过性。除发现对奈替米星的肾毒性反应与术后尿路感染之间存在显著相关性外,没有临床或治疗特征与肾毒性相关;谷浓度与血清肌酐相关。